Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial
在同时使用甘精胰岛素的糖尿病患者中,胰岛素门冬生物类似药SAR341402与原研胰岛素门冬相比的安全性、免疫原性和血糖控制:GEMELLI 1试验的12个月结果
期刊:Diabetes Technology & Therapeutics
影响因子:6.3
doi:10.1089/dia.2020.0008
Garg, Satish K; Wernicke-Panten, Karin; Wardecki, Marek; Kramer, Daniel; Delalande, Francois; Franek, Edward; Sadeharju, Karita; Monchamp, Travis; Miossec, Patrick; Mukherjee, Bhaswati; Shah, Viral N